The spread of the global COVID-19 pandemic, the lack of specific treatment and the urgent situation requires use of all resources to remedy this scourge. In the present study, using molecular docking, we identify new probable inhibitors of COVID-19 by molecules from Nigella sativa L, which is highly reputed healing herb in North African societies and both Islamic and Christian traditions. The discovery of the M pro protease structure in COVID-19 provides a great opportunity to identify potential drug candidates for treatment. Focusing on the main proteases in CoVs (3CL pro /M pro ) (PDB ID 6LU7 and 2GTB); docking of compounds from Nigella Sativa and drugs under clinical test was performed using Molecular Operating Environment software (MOE). Nigelledine docked into 6LU7 active site gives energy complex about -6.29734373 Kcal/mol which is close to the energy score given by chloroquine (-6.2930522 Kcal/mol) and better than energy score given by hydroxychloroquine (-5.57386112 Kcal/mol) and favipiravir (-4.23310471 kcal/mol). Docking into 2GTB active site showed that α-Hederin gives energy score about-6.50204802 kcal/mol whcih is better energy score given by chloroquine (-6.20844936 kcal/mol), hydroxychloroquine (-5.51465893 kcal/mol)) and favipiravir (-4.12183571kcal/mol). Nigellidine and α-Hederin appeared to have the best potential to act as COVID-19 treatment. Further, researches are necessary to testify medicinal use of identified and to encourage preventive use of Nigella Sativa against coronavirus infection.

References

Amin, A Study of the Chemical Composition of Black Cumin Oil and Its Effect on Penetration Enhancement from Transdermal Formulations, Natural Product Research, doi:10.1080/14786410902940909

Aqil, Comparative Analysis of Essential Oil Composition of Iranian and Indian Nigella Sativa L. Extracted Using Supercritical Fluid Extraction and Solvent Extraction, Evidence-Based Complementary and Alternative Medicine, doi:10.17582/journal.pjz/2018.50.6.2223.2228

Asadbeigi, Traditional Effects of Medicinal Plants in the Treatment of Respiratory Diseases and Disorders: An Ethnobotanical Study in the Urmia, Asian Pacific Journal of Tropical Medicine, doi:10.1016/S1995-7645(14)60259-5

Chaachouay, Ethnobotanical and Ethnopharmacological Study of Medicinal and Aromatic Plants Used in the Treatment of Respiratory System Disorders in the Moroccan Rif, Ethnobotany Research and Applications

Gautret, Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial, doi:10.1016/j.ijantimicag.2020.105949

Hsu, An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-Like Infectious Diseases in 2003: A Randomized, Double-Blind, and Controlled Pilot Study, Evidence-Based Complementary and Alternative Medicine, doi:10.1002/minf.202000028

Hui, i 'WHO | World Health Organization

Isaacson, Ploegh, Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection, Cell Host & Microbe, doi:10.1016/j.chom.2009.05.012

Karthikeyan, Vyas, Practical Chemoinformatics, doi:10.1007/978-81-322-1780-0

Khaerunnisa, Potential Inhibitor of COVID-19 Main Protease (M pro ) From Several Medicinal Plant Compounds by Molecular Docking Study, MEDICINE & PHARMACOLOGY, doi:10.20944/preprints202003.0226.v1

Khan, Chemical Composition of Nigella Sativa Linn: Part 2 Recent Advances, Inflammopharmacology, doi:10.1007/s10787-016-0262-7

Kokoska, Comparison of Chemical Composition and Antibacterial Activity of Nigella Sativa Seed Essential Oils Obtained by Different Extraction Methods, doi:10.4315/0362-028x-71.12.2475

Li Christopher, Corbeil, Williams, Labute, Variability in Docking Success Rates Due to Dataset Preparation, Journal of Computer-Aided Molecular Design, doi:10.1007/s10822-012-9570-1

Li, Nelfinavir Was Predicted to Be a Potential Inhibitor of 2019-NCov Main Protease by an Integrative Approach Combining Homology Modelling, Molecular Docking and Binding Free Energy Calculation, doi:10.1038/nature02145.xi'RCSBPDB-6LU7:TheCrystalStructureofCOVID-19

Lipinski, Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings, Advanced Drug Delivery Reviews, doi:10.1016/s0169-409x(00)00129-0

Liu, Nelfinavir Was Predicted to Be a Potential Inhibitor of 2019-NCov Main Protease by an Integrative Approach Combining Homology Modelling, Molecular Docking and Binding Free Energy Calculation, doi:10.1016/j.jep.2013.08.056

Mukherjee, Inhibitors of SARS-3CLpro: Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation Studies, Journal of Chemical Information and Modeling, doi:10.1021/ci1004916

Paraskevis, Full-Genome Evolutionary Analysis of the Novel Corona Virus (2019-NCoV) Rejects the Hypothesis of Emergence as a Result of a Recent Recombination Event, Infection, Genetics and Evolution, doi:10.1016/j.meegid.2020.104212.v'WHO|WorldHealthOrganization

Singh, Emerging Novel Coronavirus (2019-NCoV)-Current Scenario, Evolutionary Perspective Based on Genome Analysis and Recent Developments, Veterinary Quarterly, doi:10.1080/01652176.2020.1727993

Vi, Zhang, In Silico Screening of Chinese Herbal Medicines with the Potential to Directly Inhibit 2019 Novel Coronavirus, Journal of Integrative Medicine, doi:10.1016/j.joim.2020.02.005

Vincent Madelain, Modeling Favipiravir Antiviral Efficacy against Emerging Viruses: From Animal Studies to Clinical Trials, TIP Revista Especializada En Ciencias Químico-Biológicas, doi:10.1002/psp4.12510

Xliii Christopher, Lipinski, García, Delgado, Giménez, Lead-and Drug-like Compounds: The Rule-of-Five Revolution, doi:10.1016/j.ddtec.2004.11.007

Xxvii, Tariq, Nigella Sativa Seeds: Folklore Treatment in Modern Day Medicine, Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association, doi:10.4103/1319-3767.41725

{ 'indexed': {'date-parts': [[2024, 5, 1]], 'date-time': '2024-05-01T14:30:28Z', 'timestamp': 1714573828022}, 'posted': {'date-parts': [[2020, 4, 2]]}, 'group-title': 'Chemistry', 'reference-count': 0, 'publisher': 'American Chemical Society (ACS)', 'license': [ { 'start': { 'date-parts': [[2020, 4, 2]], 'date-time': '2020-04-02T00:00:00Z', 'timestamp': 1585785600000}, 'content-version': 'unspecified', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'accepted': {'date-parts': [[2020, 4, 2]]}, 'abstract': 'The spread of the global COVID-19 pandemic, the lack of specific treatment and the ' 'urgent situation requires use of all resources to remedy this scourge. In the present study, ' 'using molecular docking, we identify new probable inhibitors of COVID-19 by molecules from ' 'Nigella sativa L, which is highly reputed healing herb in North ' 'African societies and both Islamic and Christian traditions. The discovery of the ' 'Mpro protease structure in COVID-19 provides a great opportunity to ' 'identify potential drug candidates for treatment. Focusing on the main proteases in CoVs ' '(3CLpro/Mpro) (PDB ID 6LU7 and 2GTB); docking of ' 'compounds from Nigella Sativa and drugs under clinical test was ' 'performed using Molecular Operating Environment software (MOE). Nigelledine docked into 6LU7 ' 'active site gives energy complex about -6.29734373 Kcal/mol which is close to the energy ' 'score given by chloroquine (-6.2930522 Kcal/mol) and better than energy score given by ' 'hydroxychloroquine (-5.57386112 Kcal/mol) and favipiravir (-4.23310471 kcal/mol). Docking ' 'into 2GTB active site showed that α- Hederin gives energy score about-6.50204802 kcal/mol ' 'whcih is better energy score given by chloroquine (-6.20844936 kcal/mol), hydroxychloroquine ' '(-5.51465893 kcal/mol)) and favipiravir (-4.12183571kcal/mol). Nigellidine and α- Hederin ' 'appeared to have the best potential to act as COVID-19 treatment. Further, researches are ' 'necessary to testify medicinal use of identified and to encourage preventive use of ' 'Nigella Sativa against coronavirus infection.', 'DOI': '10.26434/chemrxiv.12055716.v1', 'type': 'posted-content', 'created': {'date-parts': [[2020, 4, 2]], 'date-time': '2020-04-02T08:19:37Z', 'timestamp': 1585815577000}, 'source': 'Crossref', 'is-referenced-by-count': 25, 'title': 'Identification of Compounds from Nigella Sativa as New Potential Inhibitors of 2019 Novel ' 'Coronasvirus (Covid-19): Molecular Docking Study.', 'prefix': '10.26434', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-2725-9798', 'authenticated-orcid': False, 'given': 'Salim', 'family': 'Bouchentouf', 'sequence': 'first', 'affiliation': [{'name': 'Doctor Tahar Moulay University of Saida'}]}, { 'ORCID': 'http://orcid.org/0000-0002-6957-6708', 'authenticated-orcid': False, 'given': 'Noureddine', 'family': 'Missoum', 'sequence': 'additional', 'affiliation': []}], 'member': '316', 'container-title': [], 'original-title': [], 'link': [ { 'URL': 'https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c7495c469df4070af43bbf/original/identification-of-compounds-from-nigella-sativa-as-new-potential-inhibitors-of-2019-novel-coronasvirus-covid-19-molecular-docking-study.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 10, 21]], 'date-time': '2021-10-21T19:06:42Z', 'timestamp': 1634843202000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://chemrxiv.org/engage/chemrxiv/article-details/60c7495c469df4070af43bbf'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 4, 2]]}, 'references-count': 0, 'URL': 'http://dx.doi.org/10.26434/chemrxiv.12055716.v1', 'relation': {}, 'subject': [], 'published': {'date-parts': [[2020, 4, 2]]}, 'subtype': 'preprint'}

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0